Prana Biotechnology (PRAN)

[interestingtome]

Neurodegenerative Diseases Market to Grow at 4.7% CAGR to 2019
DALLAS, May 14, 2015 /PRNewswire/ --

The Global Neurodegenerative Diseases Market 2015-2019 research report says reformulation of marketed drugs is boosting the growth of neurodegenerative diseases market during the period reviewed for forecasts in this research.
++++
According to this neurodegenerative diseases market report epilepsy represents a high level of unmet medical need in terms of the absence of any disease-modifying treatment. Currently, drugs used to treat the disorder are intended to treat seizures and fail to check the progression of the disease. These drugs cannot reverse the neuronal damage incurred by the patient.
+++++

The key drivers of neurodegenerative diseases market discussed in this research include unmet medical needs, increase in patient population, promising drug pipeline and special provision for rare diseases. Market trends like reformulation of marketed drugs, emerging treatment options and increase in public awareness. Analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of neurodegenerative diseases. The market includes data from the sales of various drugs used in the treatment of: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Epilepsy, Huntington's Disease and Amyotrophic Lateral Sclerosis.
Companies like Biogen Idec,+++++Prana Biotechnology++++